Population pharmacokinetic analysis and exposure–response analysis of brexpiprazole in Japanese patients with agitation in Alzheimer's dementia
Authors:
- Koushi HigashiKHKoushi Higashi
- Tomohiro SasakiTSTomohiro Sasaki
- Hikari TakahashiHTHikari Takahashi
- Yosuke KawaiYKYosuke Kawai
- Stefanie HennigSHStefanie Hennig
- Koichi ShimizuKSKoichi Shimizu
- Masami NakaiMNMasami Nakai
- Kaneyoshi TakahashiKTKaneyoshi Takahashi
- Yu NakamuraYNYu Nakamura
Open Access
- 17 July 2026
- journal article
- Published by Elsevier in Drug Metabolism and Pharmacokinetics
- Vol. 71
Abstract
No abstract availableFunding Information
- Otsuka Pharmaceutical
This publication has 16 references indexed in Scilit:
- Population pharmacokinetics of brexpiprazole in Japanese healthy subjects and patients with schizophreniaDrug Metabolism and Pharmacokinetics, 2025
- Brexpiprazole treatment for agitation in Alzheimer's dementia: A randomized studyAlzheimer's & Dementia, 2024
- Brexpiprazole for the Treatment of Agitation in Alzheimer DementiaJAMA Neurology, 2023
- Agitation in cognitive disorders: Progress in the International Psychogeriatric Association consensus clinical and research definitionInternational Psychogeriatrics, 2023
- Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled TrialsThe American Journal of Geriatric Psychiatry, 2020
- Using electronic health records to estimate the prevalence of agitation in Alzheimer disease/dementiaInternational Journal of Geriatric Psychiatry, 2018
- Pharmacokinetics and Safety of Brexpiprazole Following Multiple‐Dose Administration to Japanese Patients With SchizophreniaThe Journal of Clinical Pharmacology, 2017
- Model Evaluation of Continuous Data Pharmacometric Models: Metrics and GraphicsCPT: Pharmacometrics & Systems Pharmacology, 2016
- Computing normalised prediction distribution errors to evaluate nonlinear mixed-effect models: The npde add-on package for RComputer Methods and Programs in Biomedicine, 2008
- Disruptive Behavior as a Predictor in Alzheimer DiseaseArchives of Neurology, 2007